| Patient | Alexander the Great |
|---|---|
| Date of birth | 1993-07-20 |
| Identifiers | MRN HR-AC002-SYN; SSN (made up) 000-02-3567 |
| Document date | 2026-11-01 |
| Author | Theodora Papadakis-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for left chest wall pain and breathlessness on exertion since an old penetrating chest wound, with heavy episodic drinking and recent bereavement found at the visit: chest X-ray, spirometry, liver tests, PEth, AUDIT, PHQ-9, safety assessment, and a pulmonology consultation. Concerns: Pain at the old chest wound and breathlessness that slow him on the march; He wants to drink less at banquets without giving up his officers' company; Grief for his closest companion, and poor sleep since. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for chest wall pain, no more than 2,000 mg in a day while he is drinking heavily | One to two tablets by mouth every six hours as needed; no more than four tablets a day | Oral route | 2026-03-09 | active | S |
| Thiamine 100 mg oral tablet once daily for three months | One tablet by mouth daily | Oral route | 2026-03-09 | active | S |
| Lidocaine 5% medicated patch, one patch over the painful scar for up to 12 hours in each 24 hours | Apply one patch to the painful area for up to 12 hours, then remove for 12 hours | Topical route | 2026-03-23 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Chest X-ray, PA and lateral: smooth pleural thickening along the left lateral and posterior lower chest with blunting of the left costophrenic angle; healed fracture of the left fifth rib anterolaterally; no pneumothorax, effusion or radio-opaque foreign body; lungs otherwise clear; heart and mediastinum normal | 2026-03-09 to 2026-03-09 | completed | S |
| Spirometry before bronchodilator, ATS/ERS 2019 acceptability and repeatability met | 2026-03-09 to 2026-03-09 | completed | S |
| CT of the chest without contrast: localized pleural thickening up to 7 mm over the left lateral and posterior lower chest with a thin rim of calcification, consistent with an old organized hemothorax; a linear subpleural scar along the wound track in the left lower lobe with slight volume loss; healed fracture of the left fifth rib with callus; no retained metallic or other foreign body; no bronchopleural fistula, loculated fluid, empyema, nodule or emphysema; right lung normal | 2026-03-23 to 2026-03-23 | completed | S |
| Lung volumes by body plethysmography and single-breath diffusing capacity | 2026-03-23 to 2026-03-23 | completed | S |
| Six-minute walk test on a 30-meter course | 2026-03-23 to 2026-03-23 | completed | S |
| Repeat spirometry before bronchodilator | 2026-05-11 to 2026-05-11 | completed | S |
| Irrigation and simple repair of a 4 cm laceration of the left forearm under local anesthetic (lidocaine 1%), six interrupted nylon sutures | 2026-04-06 to 2026-04-06 | completed | S |
| Advance care planning conversation, about 20 minutes | 2026-04-27 to 2026-04-27 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-04-06 | Tdap (tetanus, diphtheria and acellular pertussis), one dose for a wound, last tetanus booster seven years ago | completed | S |
| 2026-04-27 | Hepatitis A vaccine, adult, first of two doses, for travel | completed | S |
| 2026-04-27 | Typhoid Vi polysaccharide vaccine, one dose, for travel | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 334 to 332 BC | Battle wounds in his early twenties: a blow to the head, a sword wound to the thigh, and a catapult bolt into the shoulder that was slow to heal | D (CLM-0002) |
| 333 BC | Grave illness with high fever, convulsions and sleeplessness after bathing in a cold river; recovered under his physician's treatment | D (CLM-0005) |
| 326 or 325 BC | Penetrating arrow wound of the left chest in battle, with heavy bleeding, fainting and air escaping from the wound; the arrowhead was cut out from against a rib; a long, slow recovery | D (CLM-0003) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Pain at the old chest wound and breathlessness that slow him on the march | active | S |
| He wants to drink less at banquets without giving up his officers' company | active | S |
| Grief for his closest companion, and poor sleep since | active | S |
Most recent measures: Forced vital capacity [Volume] Respiratory system 4.14 on 2026-05-11; FVC measured/predicted 83 on 2026-05-11; FEV1 3.46 on 2026-05-11; FEV1 measured/predicted 83 on 2026-05-11; FEV1/FVC 0.84 on 2026-05-11; Hemoglobin [Mass/volume] in Blood 15.1 on 2026-03-09; MCV [Entitic mean volume] in Red Blood Cells by Automated count 98 on 2026-03-09; Platelets [#/volume] in Blood by Automated count 214 on 2026-03-09; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-03-09; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-03-09; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-03-09; Glucose [Mass/volume] in Serum or Plasma 91 on 2026-03-09; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 104 on 2026-03-09; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34 on 2026-04-20; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36 on 2026-04-20; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 58 on 2026-04-20; Albumin [Mass/volume] in Serum or Plasma 4.5 on 2026-03-09; Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 on 2026-03-09; Phosphatidylethanol [Mass/volume] in Blood 31 on 2026-05-11; Total score [AUDIT] 19 on 2026-03-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 2026-05-11; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 2026-03-09; Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 on 2026-05-11; Total lung capacity 5.28 on 2026-03-23; Total lung capacity measured/predicted by Plethysmograph body box 79 on 2026-03-23; Diffusion capacity.carbon monoxide 31.4 on 2026-03-23; Six minute walk test 548 on 2026-03-23; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-04-27; Total score [AUDIT-C] 3 on 2026-05-11 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Left chest wall pain at the scar of an old penetrating arrow wound, with breathlessness on exertion and a reduced FVC (78 percent predicted) with a normal FEV1/FVC ratio, and heavy episodic drinking (AUDIT 19, PEth 236 ng/mL), found at intake; cause and extent under evaluation with a pulmonology consultation and an addiction medicine assessment | resolved | confirmed | R07.89 | S — Synthetic presenting problem anchored to the documented chest wound and the documented drinking parties; superseded at the consultation, when the chest wall pain, the pleural thickening and the alcohol use disorder were diagnosed. |
| Chronic post-traumatic chest wall pain: intercostal neuropathic pain at the healed left chest wound and fifth rib fracture, with tenderness and a small area of allodynia over the scar | active | confirmed | G89.21 | S — Synthetic modern diagnosis made at the consultation, anchored to the documented arrow wound; not a claim about his real chest. |
| Localized left pleural thickening (fibrothorax) from an old organized hemothorax after a penetrating chest wound, with a mild restrictive defect (TLC 79 percent predicted) and normal gas transfer; no retained foreign body, fistula or trapped lung on CT | active | confirmed | J94.1 | S — Synthetic modern finding of the CT and lung function tests at the consultation, anchored to the documented arrow wound; the retrospective pneumothorax (CLM-0004) is not used. |
| Alcohol use disorder, mild (three DSM-5-TR criteria): drinking more than intended at banquets, riding after drinking, and arguments with his officers while drunk; ten or more drinks on two or three nights a week, more since his bereavement; no withdrawal; AUDIT 19; PEth 236 ng/mL | active | confirmed | F10.10 | S — Synthetic modern diagnosis made with the addiction medicine clinician at the consultation visit, anchored to the documented drinking parties; the criteria, amounts and scores are synthetic. The diagnosis is mild, in keeping with the disputed evidence (CLM-0008). |
| Bereavement five months after the death of his closest companion since boyhood, with depressive symptoms (PHQ-9 12, item 9 scored 0) that do not meet criteria for a major depressive episode; prolonged grief disorder cannot be diagnosed before twelve months | active | confirmed | Z63.4 | S — Synthetic modern assessment anchored to the documented bereavement; DSM-5-TR codes uncomplicated bereavement as Z63.4 whatever the relationship. Not a claim about his real mental health. |
| Laceration of the left forearm, 4 cm, from a practice blade in a training drill; clean edges, no tendon, nerve or vessel injury; repaired with sutures; healed | resolved | confirmed | S51.812A | S — Synthetic acute injury; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-09 | Forced vital capacity [Volume] Respiratory system | 3.92 | L | Lower limit of normal for his age and height (GLI 2012); predicted 5.00 L | Low | S |
| 2026-03-09 | FVC measured/predicted | 78 | % | >=80% | Low | S |
| 2026-03-09 | FEV1 | 3.29 | L | Lower limit of normal for his age and height (GLI 2012); predicted 4.15 L | Low | S |
| 2026-03-09 | FEV1 measured/predicted | 79 | % | >=80% | Low | S |
| 2026-03-09 | FEV1/FVC | 0.84 | {ratio} | Lower limit of normal for his age (GLI 2012) | Normal | S |
| 2026-03-09 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13-17 g/dL | Normal | S |
| 2026-03-09 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 98 | fL | 80-100 fL | Normal | S |
| 2026-03-09 | Platelets [#/volume] in Blood by Automated count | 214 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-09 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-09 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-09 | Glucose [Mass/volume] in Serum or Plasma | 91 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 104 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-09 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 10-40 U/L | High | S |
| 2026-03-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 9-46 U/L | Normal | S |
| 2026-03-09 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 96 | U/L | 8-61 U/L | High | S |
| 2026-03-09 | Albumin [Mass/volume] in Serum or Plasma | 4.5 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-09 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.2-1.2 mg/dL | Normal | S |
| 2026-03-09 | Phosphatidylethanol [Mass/volume] in Blood | 236 | ng/mL | Below 20 ng/mL abstinence or light drinking; 20 to 200 significant drinking; above 200 heavy drinking | High | S |
| 2026-03-09 | Total score [AUDIT] | 19 | {score} | S | ||
| 2026-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 12 | {score} | S | ||
| 2026-03-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S | ||
| 2026-03-09 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 6 | {score} | S | ||
| 2026-03-23 | Total lung capacity | 5.28 | L | Lower limit of normal; predicted 6.65 L | Low | S |
| 2026-03-23 | Total lung capacity measured/predicted by Plethysmograph body box | 79 | % | Below the lower limit of normal (about 80 percent predicted) indicates restriction | Low | S |
| 2026-03-23 | Diffusion capacity.carbon monoxide | 31.4 | mL/min/mm[Hg] | Lower limit of normal for his age and height; predicted 33.5 | Normal | S |
| 2026-03-23 | Six minute walk test | 548 | m | Predicted about 640 m for his age, sex, height and weight; lower limit about 520 m | Normal | S |
| 2026-03-23 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 6 | {score} | S | ||
| 2026-04-20 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 10-40 U/L | Normal | S |
| 2026-04-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 36 | U/L | 9-46 U/L | Normal | S |
| 2026-04-20 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 58 | U/L | 8-61 U/L | Normal | S |
| 2026-04-20 | Phosphatidylethanol [Mass/volume] in Blood | 88 | ng/mL | Below 20 ng/mL abstinence or light drinking; 20 to 200 significant drinking; above 200 heavy drinking | High | S |
| 2026-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-04-20 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 2026-04-27 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-05-11 | Forced vital capacity [Volume] Respiratory system | 4.14 | L | Lower limit of normal for his age and height (GLI 2012); predicted 5.00 L | Normal | S |
| 2026-05-11 | FVC measured/predicted | 83 | % | >=80% | Normal | S |
| 2026-05-11 | FEV1 | 3.46 | L | Lower limit of normal for his age and height (GLI 2012); predicted 4.15 L | Normal | S |
| 2026-05-11 | FEV1 measured/predicted | 83 | % | >=80% | Normal | S |
| 2026-05-11 | FEV1/FVC | 0.84 | {ratio} | Lower limit of normal for his age (GLI 2012) | Normal | S |
| 2026-05-11 | Phosphatidylethanol [Mass/volume] in Blood | 31 | ng/mL | Below 20 ng/mL abstinence or light drinking; 20 to 200 significant drinking; above 200 heavy drinking | High | S |
| 2026-05-11 | Total score [AUDIT-C] | 3 | {score} | S | ||
| 2026-05-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-05-11 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-09 | Body height | 170 | cm | S |
| 2026-03-09 | Body weight | 72.4 | kg | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 25.1 | kg/m2 | S |
| 2026-03-09 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-03-09 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-03-09 | Heart rate | 82 | /min | S |
| 2026-03-09 | Respiratory rate | 16 | /min | S |
| 2026-03-09 | Body temperature | 36.7 | Cel | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-03-23 | Body height | 170 | cm | S |
| 2026-03-23 | Body weight | 72 | kg | S |
| 2026-03-23 | Body mass index (BMI) [Ratio] | 24.9 | kg/m2 | S |
| 2026-03-23 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-03-23 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-03-23 | Heart rate | 76 | /min | S |
| 2026-03-23 | Respiratory rate | 16 | /min | S |
| 2026-03-23 | Body temperature | 36.6 | Cel | S |
| 2026-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-04-06 | Body height | 170 | cm | S |
| 2026-04-06 | Body weight | 71.8 | kg | S |
| 2026-04-06 | Body mass index (BMI) [Ratio] | 24.8 | kg/m2 | S |
| 2026-04-06 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-04-06 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-04-06 | Heart rate | 84 | /min | S |
| 2026-04-06 | Respiratory rate | 16 | /min | S |
| 2026-04-06 | Body temperature | 36.7 | Cel | S |
| 2026-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-04-20 | Body height | 170 | cm | S |
| 2026-04-20 | Body weight | 71.6 | kg | S |
| 2026-04-20 | Body mass index (BMI) [Ratio] | 24.8 | kg/m2 | S |
| 2026-04-20 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-04-20 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-04-20 | Heart rate | 70 | /min | S |
| 2026-04-20 | Respiratory rate | 14 | /min | S |
| 2026-04-20 | Body temperature | 36.6 | Cel | S |
| 2026-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-04-27 | Body height | 170 | cm | S |
| 2026-04-27 | Body weight | 71.5 | kg | S |
| 2026-04-27 | Body mass index (BMI) [Ratio] | 24.7 | kg/m2 | S |
| 2026-04-27 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-04-27 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-04-27 | Heart rate | 68 | /min | S |
| 2026-04-27 | Respiratory rate | 14 | /min | S |
| 2026-04-27 | Body temperature | 36.6 | Cel | S |
| 2026-04-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-05-11 | Body height | 170 | cm | S |
| 2026-05-11 | Body weight | 71.5 | kg | S |
| 2026-05-11 | Body mass index (BMI) [Ratio] | 24.7 | kg/m2 | S |
| 2026-05-11 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-05-11 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-05-11 | Heart rate | 66 | /min | S |
| 2026-05-11 | Respiratory rate | 14 | /min | S |
| 2026-05-11 | Body temperature | 36.6 | Cel | S |
| 2026-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-03-09 | Establishing care for left chest wall pain and breathlessness on exertion since an old penetrating chest wound, with heavy episodic drinking and recent bereavement found at the visit: chest X-ray, spirometry, liver tests, PEth, AUDIT, PHQ-9, safety assessment, and a pulmonology consultation | finished | S |
| 2026-03-23 | Two-week review, seen the same day by pulmonology and by the clinic's addiction medicine clinician: CT of the chest, lung volumes, gas transfer and six-minute walk; chest wall pain plan; DSM-5-TR assessment and a drinking goal | finished | S |
| 2026-04-20 | Six-week review: chest wall pain and the exercise program, drinking and PEth, liver tests, grief and mood, safety, and the healed forearm wound | finished | S |
| 2026-05-11 | Nine-week review: repeat spirometry, pain, drinking and PEth, AUDIT-C, mood, safety and the plan ahead | finished | S |
| 2026-04-06 | Same-day sick visit for a left forearm laceration | finished | S |
| 2026-04-27 | Periodic adult preventive visit, with travel and campaign health | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Chest: chest X-ray and spirometry at intake; CT of the chest and lung volumes with diffusing capacity and a six-minute walk at the consultation; repeat spirometry after two to three months of the exercise program | completed | GL-ATS-SPIRO-2019, GL-ERS-ATS-INTERP-2022, GL-BTS-PLEURAL-2023 | S |
| Pulmonology consultation for chest wall pain and reduced lung function after a penetrating chest wound: a retained fragment, pleural thickening or trapped lung, the need for surgery, pain treatment without opioids, fitness for heavy exertion, and lung function follow-up | completed | GL-BTS-PLEURAL-2023, GL-ERS-ATS-INTERP-2022 | S |
| Chest wall pain: acetaminophen up to 2,000 mg a day; no opioids, tramadol, gabapentinoids or benzodiazepines while he drinks heavily; no regular anti-inflammatory tablets with heavy drinking | completed | GL-CDC-OPIOID-2022 | S |
| Lidocaine 5% patch over the scar for up to 12 hours a day; an intercostal nerve block if pain stays above 4 of 10 after six weeks; a four-week telephone check on the patch | completed | GL-CDC-OPIOID-2022, GL-BTS-PLEURAL-2023 | S |
| Exercise and breathing program: physical therapy for thoracic mobility and scar desensitization, deep-breathing exercises, and graded aerobic and strength training back to long marches; no decortication, which is kept for a trapped lung or severe restriction | completed | GL-BTS-PLEURAL-2023, GL-ERS-ATS-INTERP-2022 | S |
| Alcohol: AUDIT, DSM-5-TR criteria and PEth with consent; liver tests; brief counseling at intake and sessions with the clinic's addiction medicine clinician; withdrawal risk assessed (no withdrawal expected with his pattern); thiamine for three months; PEth and liver tests at follow-up | completed | GL-USPSTF-ALC-2018, GL-SUD-2021, GL-APA-AUD-2018 | S |
| Drinking goal chosen with him for a mild alcohol use disorder: no more than four drinks on any day and fourteen in a week, two alcohol-free days a week, water between drinks at banquets, and no riding or driving after drinking; naltrexone offered and declined, to be offered again if the goal is not met | completed | GL-SUD-2021, GL-APA-AUD-2018 | S |
| Grief and mood: sessions with the clinic's behavioral health clinician, sleep routine, PHQ-9 every four to six weeks; reassess for prolonged grief disorder only if intense grief persists beyond twelve months; antidepressant only if a major depressive episode develops | completed | GL-CMID-2026, GL-APA-PGD-2022, GL-USPSTF-DEP-2023 | S |
| Safety: a structured safety assessment, the service pistol kept in the armory off duty and never carried after drinking, a written safety plan, the 988 Suicide & Crisis Lifeline, and safety review at every visit | completed | GL-SUICIDE-2024, GL-USPSTF-DEP-2023 | S |
| Travel and campaign health for months in Mesopotamia: no malaria chemoprophylaxis where CDC lists no transmission, reviewed before any other travel; insect and tick precautions; safe food and water; hepatitis A and typhoid vaccines; rabies pre-exposure vaccination offered | completed | GL-CDC-TRAVEL-IRAQ, GL-ACIP-HAV-2020 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find out why the old wound still hurts and why he is breathless, and whether anything remains in the chest | 2026-03-23 | completed | Post-traumatic intercostal pain and a localized fibrothorax with mild restriction; no retained fragment, fistula or trapped lung; no surgery needed | S |
| Chest wall pain 3 of 10 or less on exertion, without opioids | 2026-05-11 | completed | 6 to 2 of 10 on the lidocaine patch, acetaminophen and the exercise program | S |
| Back to long marches and runs without stopping for breath | 2026-08-10 | active | Six-minute walk 548 m at the consultation; FVC 78 to 83 percent predicted; running again at nine weeks | S |
| No more than four drinks on any day and fourteen in a week, no riding or driving after drinking, and two or more alcohol-free days a week | 2026-08-10 | active | PEth 236 to 31 ng/mL; within his limits at all but one banquet | S |
| Sleep seven hours, and room to grieve | 2026-08-10 | active | PHQ-9 12 to 5; sleeping six to seven hours | S |
Structured synthetic safety assessment on 2026-03-09: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up. Risk factors reviewed without detail: recent bereavement, depressive symptoms (PHQ-9 12), heavy episodic drinking, chronic pain, and access to a service weapon. The service pistol stays in the unit armory off duty and he will not carry it after drinking; he will not ride or drive after drinking. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) and the clinic's number were written on a card he carries. Safety is reviewed at every visit [S]